Newly activated UI Cancer Center Clinical Trials

Newly activated UI Cancer Center Clinical Trials

The following studies have recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov.

For more information or questions about a study, please email cancertrials@uic.edu or call 312-355-5112.

 

A Phase 2a Open-label Study to Investigate Safety and Tolerability (Including the MTD), Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of MT-3724 in Combination With Lenalidomide in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Sponsor: Molecular Templates, Inc.
Principal Investigator: David Peace, MD


 

Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients with Relapsed or Refractory DLBCL

Sponsor: Molecular Templates, Inc.
Principal Investigator: David Peace, MD


 

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study

Sponsor: National Cancer Institute
Principal Investigator: Oana Danciu, MD

Leave a Reply